Onconetix – since formally dropping its once-hot pursuit of a universal flu vaccine in December 2023 – has tried to make ...

Andrew J. Oakley, Chairman of the Board of Onconetix, stated, “We are excited about the opportunity to combine forces with Ocuvex, whose pipeline of commercial and late clinical stage ophthalmic ...

Seventy-four Oklahoma legislators, all Republicans, signed a letter written by the Oklahoma Petroleum Alliance to Oklahoma’s ...